This book deals with the noteworthy advancement in the production of bioactive metabolites from microbes and their pharmacological significance. It highlights the pharmacological potential of marine microbes and endophytic fungi and their bioactive secondary metabolites. Emphasis is also given on the significance of probiotics and their specialized molecules in human health and disease as well as their role in dietary intervention for reducing the risk of non-alcoholic fatty liver disease. This work also serves as excellent reference material for researchers, students and academicians in the field of natural product chemistry, pharmacology and applied microbiology.

Autorentext

Divya Arora is working in Microbial Biotechnology Division at CSIR- Indian Institute of Integrative Medicine, Jammu.  She has obtained her Ph.D. from the Academy of Scientific and Innovative Research (AcSIR) at the CSIR-Indian Institute of Integrative Medicine, Jammu. 

Chetan Sharma is working as Research Associate, College of Dairy Science and Technology, Guru Angad Dev Veterinary and Animal Science University, Ludhiana, India. 

Sundeep Jaglan, 38, is working as Scientist in the Microbial Biotechnology Division atthe CSIR-Indian Institute of Integrative Medicine, Jammu, India. 

Eric Lichtfouse, 58, is a biogeochemist at the University of Aix-Marseille, France. He is the inventor of carbon-13 dating and author of the book Scientific Writing for Impact Factor Journals. He is Chief Editor and founder of Environmental Chemistry Letters, Sustainable Agriculture Reviews and Environmental Chemistry for a Sustainable World (Springer Nature), and Publier La Science (INRA). His actual research interests include soil carbon sequestration and temporal pools of individual substances in complex media.****

Klappentext
This book deals with the noteworthy ****advancement in the production of bioactive metabolites from microbes and their pharmacological significance. It highlights the pharmacological potential of marine microbes and endophytic fungi and their bioactive secondary metabolites. Emphasis is also given on the significance of probiotics and their specialized molecules in human health and disease as well as their role in dietary intervention for reducing the risk of non-alcoholic fatty liver disease. This work also serves as excellent reference material for researchers, students and academicians in the field of natural product chemistry, pharmacology and applied microbiology.

Inhalt

1. Pharmacological potential of marine microbes.- 2.Antiparasitics from microorganisms: current status and future prospects.- 3. Bioactive compounds from Nocardia: biosynthesis and production.- 4. Bioactive metabolites from microorganisms for healthcare: types and delivery routes.- 5. Siderophores: A novel approach to fight antimicrobial resistance.- 6. An update on bioactive natural products from endophytic fungi of medicinal plants.- 7. Microbes, their metabolites and effector molecules: a pharmacological perspective for host-microbiota interaction.- 8. Probiotics as a dietary intervention for reducing the risk of non-alcoholic fatty liver disease**.**